{"id":187935,"name":"SPECIALTY TOBACCO COUNCIL INC","slug":"specialty-tobacco-council-inc","state":"NC","country":"United States of America","description":"","totalSpending":0,"filings":33,"yearlySpending":[{"year":2018,"income":0},{"year":2019,"income":0},{"year":2020,"income":0},{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0},{"year":2024,"income":0},{"year":2025,"income":0}],"issues":[{"code":"TRD","display":"Trade (domestic/foreign)"},{"code":"TOB","display":"Tobacco"}],"firms":["SPECIALTY TOBACCO COUNCIL, INC."],"lobbyists":["HENRY ROEMER"],"govEntities":["Executive Office of the President (EOP)","Food & Drug Administration (FDA)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","U.S. Trade Representative (USTR)","White House Office"],"sampleDescriptions":["To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.","FDA regulation of tobacco products, PL 111-31.  To ensure fair and reasonable regulation of industry.","To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31.","FDA regulation of tobacco products, PL 111-31.  To ensure fair and reasonable regulation of industry.","To ensure that FDA regulation of tobacco products is consistent with US trade obligations regarding WTO-permissable restrictions on trade, PL 111-31."]}